Related Experiment Video
Updated: Feb 14, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Hypertension-Induced Cerebral Small Vessel Disease Leading to Cognitive Impairment
Yang Liu1, Yan-Hong Dong2, Pei-Yuan Lyu1
1Graduate School, Hebei Medical University, Shijiazhuang, Hebei 050017; Department of Neurology, Hebei General Hospital, Shijiazhuang, Hebei 050051, China.
Insights
Hypertension causes changes in cerebral small vessel disease (CSVD), leading to cognitive impairment. Managing blood pressure is crucial for preventing cognitive decline associated with CSVD.
Area of Science:
- Neurology
- Cardiovascular Science
- Gerontology
Background:
- Alzheimer's disease and vascular dementia account for over 80% of dementia cases.
- Hypertension is a shared risk factor for both Alzheimer's disease and vascular dementia.
- Cerebral small vessel disease (CSVD) is strongly linked to hypertension and cognitive impairment.
Purpose of the Study:
- To review pathophysiological changes in CSVD caused by hypertension.
- To explore the relationship between CSVD and cognitive impairment.
Main Methods:
- PubMed database search for literature up to December 2017.
- Keywords included hypertension, CSVD, white matter lesions, enlarged perivascular spaces, lacunar infarcts, cerebral microbleeds, and cognitive impairment.
- Analysis of hypertension-induced CSVD changes and their correlation with cognitive impairment.
Main Results:
- Hypertension leads to progressive changes in cerebral small vessels, including lesions, inflammation, and blood-brain barrier damage.
- Poor blood pressure control exacerbates CSVD, contributing to cognitive decline.
- Both isolated and co-occurring CSVD impact cognitive function through cholinergic system or tract dysfunction.
Conclusions:
- Hypertensive vasculopathy and inflammation in CSVD are key indicators of cognitive impairment development.
- Further research is needed to validate the link between blood pressure levels, CSVD progression, and cognitive status.
- Investigating the impact of CSVD characteristics (number, volume, location) on cognitive impairment is essential.
Objective:
Alzheimer's disease and vascular dementia are responsible for more than 80% of dementia cases. These two conditions share common risk factors including hypertension. Cerebral small vessel disease (CSVD) is strongly associated with both hypertension and cognitive impairment. In this review, we identify the pathophysiological changes in CSVD that are caused by hypertension and further explore the relationship between CSVD and cognitive impairment.
Data Sources:
We searched and scanned the PubMed database for recently published literatures up to December 2017. We used the keywords of "hypertension", "cerebral small vessel disease", "white matter lesions", "enlarged perivascular spaces", "lacunar infarcts", "cerebral microbleeds", and "cognitive impairment" in the database of PubMed.
Study Selection:
Articles were obtained and reviewed to analyze the hypertension-induced pathophysiological changes that occur in CSVD and the correlation between CSVD and cognitive impairment.
Results:
In recent years, studies have demonstrated that hypertension-related changes (e.g., small vascular lesions, inflammatory reactions, hypoperfusion, oxidative stress, damage to autoregulatory processes and the blood-brain barrier, and cerebral amyloid angiopathy) can occur over time in cerebral small vessels, potentially leading to lower cognitive function when blood pressure (BP) control is poor or lacking. Both isolated and co-occurrent CSVD can lead to cognitive deterioration, and this effect may be attributable to a dysfunction in either the cholinergic system or the functionality of cortical and subcortical tracts.
Conclusions:
We explore the currently available evidence about the hypertensive vasculopathy and inflammatory changes that occur in CSVD. Both are vital prognostic indicators of the development of cognitive impairment. Future studies should be performed to validate the relationship between BP levels and CSVD progression and between the numbers, volumes, and anatomical locations of CSVD and cognitive impairment.
Related Concept Videos
Cognitive Dissonance
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hypertension I: Introduction
Hypertension II: Pathophysiology
Hypertension V: Nursing Management
Phase-lead and Phase-lag Controllers

